SPC Logo

Fluarix

Last Updated on eMC 23-Jun-2014 View document  | GlaxoSmithKline UK Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 23-Jun-2014 and displayed until Current

Reasons for adding or updating:

  • Change to section 4 - how to report a side effect
  • Change to section 6 - what the product contains
  • Change to section 6 - date of revision

Updated on 12-Mar-2014 and displayed until 23-Jun-2014

Reasons for adding or updating:

  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - date of revision

Updated on 03-Sep-2013 and displayed until 12-Mar-2014

Reasons for adding or updating:

  • Change to section 6 - what the product contains
  • Change to section 6 - date of revision

Updated on 14-May-2013 and displayed until 03-Sep-2013

Reasons for adding or updating:

  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision

Updated on 03-Sep-2012 and displayed until 14-May-2013

Reasons for adding or updating:

  • Change of active ingredient
  • Change to date of revision

Updated on 16-Mar-2012 and displayed until 03-Sep-2012

Reasons for adding or updating:

  • Change to warnings or special precautions for use
  • Change to date of revision

Updated on 31-Oct-2011 and displayed until 16-Mar-2012

Reasons for adding or updating:

  • Unknown

Updated on 25-May-2011 and displayed until 31-Oct-2011

Reasons for adding or updating:

  • Change to date of revision

Updated on 10-Aug-2010 and displayed until 25-May-2011

Reasons for adding or updating:

  • Change of trade or generic name
  • Change to Further Information section
  • Change to date of revision
  • Change of contra-indications

Updated on 21-Sep-2009 and displayed until 10-Aug-2010

Reasons for adding or updating:

  • Change of active ingredient
  • Change to date of revision

Updated on 11-Feb-2009 and displayed until 21-Sep-2009

Reasons for adding or updating:

  • Change to dosage and administration

Updated on 06-Feb-2009 and displayed until 11-Feb-2009

Reasons for adding or updating:

  • Improved Electronic Presentation

Updated on 26-Aug-2008 and displayed until 06-Feb-2009

Reasons for adding or updating:

  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to date of revision
  • Change of active ingredient

Updated on 05-Sep-2007 and displayed until 26-Aug-2008

Reasons for adding or updating:

  • Change to date of revision
  • Change of active ingredient

Updated on 26-Sep-2006 and displayed until 05-Sep-2007

Reasons for adding or updating:

  • Change of active ingredient
  • Change to date of revision

Updated on 29-Sep-2005 and displayed until 26-Sep-2006

Reasons for adding or updating:

  • Change of active ingredient
  • Change of inactive ingredient
  • Change to date of revision

Updated on 18-Aug-2004 and displayed until 29-Sep-2005

Reasons for adding or updating:

  • Change of active ingredient
  • Change to date of revision

Updated on 15-Jul-2003 and displayed until 18-Aug-2004

Reasons for adding or updating:

  • Update to PIL

Updated on 20-Aug-2002 and displayed until 15-Jul-2003

Reasons for adding or updating:

  • Update to PIL

Updated on 10-May-2002 and displayed until 20-Aug-2002

Reasons for adding or updating:

  • Update to PIL

Updated on 01-Nov-2000 and displayed until 10-May-2002

Reasons for adding or updating:

  • No reasons supplied

Company contact details

GlaxoSmithKline UK

Company image
Address

Stockley Park West, Uxbridge, Middlesex, UB11 1BT

Fax

+44 (0)208 990 4328

Telephone

+44 (0)800 221 441

Medical Information e-mail

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

influenza vaccine (split virion, inactivated)

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue